Use of an in vitro model and yeast two-hybrid system to investigate the pathogenesis of hepatitis C

Intervirology

Volumn 49, Issue 1-2, 2006, Pages 44-50

  Seng, Gee Lim ^a,b   Yee, Joo Tan ^a   Phuay, Yee Goh ^a   Siew, Pheng Lim ^a   Wan, Jin Hong ^a  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Chemokines; Hepatitis C virus; Mutations; Pathogenesis; Plasmid, inducible; Protein protein interactions; Viral replication; Yeast two hybrid system

Indexed keywords

CASPASE INHIBITOR; CD81 ANTIGEN; CHEMOKINE; CHIMERIC PROTEIN; HELICASE; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN P68; TRANSFERRIN RECEPTOR;

APOPTOSIS; CONFERENCE PAPER; CYTOPLASM; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; HELA CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IN VITRO STUDY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TWO HYBRID SYSTEM; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; YEAST;

ANTIGENS, CD; APOPTOSIS; CHEMOKINE CCL2; DEAD-BOX RNA HELICASES; GENOME, VIRAL; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; PLASMIDS; PROTEIN BINDING; PROTEIN KINASES; RANTES; RECEPTORS, LIPOPROTEIN; RECEPTORS, TRANSFERRIN; RECEPTORS, VIRUS; RECOMBINANT FUSION PROTEINS; RNA HELICASES; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES; UP-REGULATION; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 24944446747     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087262     Document Type: Conference Paper

References (29)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359-362.
2. Penin F, Dubuisson J, Rey FA, Moradpour D, Pawlotsky JM: Structural biology of hepatitis C virus. Hepatology 2004;39:5-19.
3. Moradpour D, Brass V, Gosert R, Wolk B, Blum HE: Hepatitis C: Molecular virology and antiviral targets. Trends Mol Med 2002;8:476-482.
4. Giannini C, Brechot C: Hepatitis C virus biology. Cell Death Differ 2003;10:S27-S38.
5. Dubuisson J, Penin F, Moradpour D: Interaction of hepatitis C virus proteins with host cell membranes and lipids. Trends Cell Biol 2002;12:517-523.
6. Pavio N, Lai MM: The hepatitis C virus persistence: How to evade the immune system? J Biosci 2003;28:287-304.
7. Bartenschlager R, Kaul A, Sparacio S: Replication of the hepatitis C virus in cell culture. Antiviral Res 2003;60:91-102.
8. Lim SP, Khu YL, Hong WJ, Tay A, Ting AE, Lim SG, Tan YH: Identification and molecular characterisation of the complete genome of a Singapore isolate of hepatitis C virus: Sequence comparison with other strains and phylogenetic analysis. Virus Genes 2001;23:89-95.
9. Lim SP, Soo HM, Tan YH, Brenner S, Horstmann H, MacKenzie JM, Ng ML, Lim SG, Hong W: Inducible system in human hepatoma cell lines for hepatitis C virus production. Virology 2002;303:79-99.
10. Wolk B, Sansonno D, Krausslich HG, Dammacco F, Rice CM, Blum HE, Moradpour D: Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J Virol 2000;74:2293-2304.
11. Moradpour D, Wakita T, Wands JR, Blum HE: Tightly regulated expression of the entire hepatitis C virus structural region in continuous human cell lines. Biochem Biophys Res Commun 1998;246:920-924.
12. Myung J, Khalap N, Kalkeri G, Garry R, Dash S: Inducible model to study negative strand RNA synthesis and assembly of hepatitis C virus from a full-length cDNA clone. J Virol Methods 2001;94:55-67.
13. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R: Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999;285:110-113.
14. Peterson KE, Robertson SJ, Portis JL, Chesebro B: Differences in cytokine and chemokine responses during neurological disease induced by polytropic murine retroviruses Map to separate regions of the viral envelope gene. J Virol 2001;75:2848-2856.
15. Lin YL, Liu CC, Chuang JI, Lei HY, Yeh TM, Lin YS, Huang YH, Liu HS: Involvement of oxidative stress, NF-IL-6, and RANTES expression in dengue-2-virus-infected human liver cells. Virology 2000;276:114-126.
16. Matikainen S, Pirhonen J, Miettinen M, Lehtonen A, Govenius-Vintola C, Sareneva T, Julkunen I: Influenza A and sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages. Virology 2000;276:138-147.
17. Soo HM, Garzino-Demo A, Hong W, Tan YH, Tan YJ, Goh PY, Lim SG, Lim SP: Expression of a full-length hepatitis C virus cDNA up-regulates the expression of CC chemokines MCP-1 and RANTES. Virology 2002;303:253-277.
18. Hellier S, Frodsham AJ, Hennig BJ, Klenerman P, Knapp S, Ramaley P, Satsangi J, Wright M, Zhang L, Thomas HC, Thursz M, Hill AV: Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology 2003;38:1468-1476.
19. Muhlbauer M, Bosserhoff AK, Hartmann A, Thasler WE, Weiss TS, Herfarth H, Lock G, Scholmerich J, Hellerbrand C: A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 2003;125:1085-1093.
20. Heydtmann M, Shields P, McCaughan G, Adams D: Cytokines and chemokines in the immune response to hepatitis C infection. Curr Opin Infect Dis 2001;14:279-287.
21. Khu YL, Koh E, Lim SP, Tan YH, Brenner S, Lim SG, Hong WJ, Goh PY: Mutations that affect dimer formation and helicase activity of the hepatitis C virus helicase. J Virol 2001;75:205-214.
22. Goh PY, Tan YJ, Lim SP, Lim SG, Tan YH, Hong WJ: The hepatitis C virus core protein interacts with NS5A and activates its caspase-mediated proteolytic cleavage. Virology 2001;290:224-236.
23. Goh PY, Tan YJ, Lim SP, Tan YH, Lim SG, Fuller-Pace F, Hong W: Cellular RNA helicase p68 relocalization and interaction with the hepatitis C virus (HCV) NS5B protein and the potential role of p68 in HCV RNA replication. J Virol 2004;78:5288-5298.
24. Tellinghuisen TL, Rice CM: Interaction between hepatitis C virus proteins and host cell factors. Curr Opin Microbiol 2002;5:419-427.
25. Dimitrova M, Imbert I, Kieny MP, Schuster C: Protein-protein interactions between hepatitis C virus nonstructural proteins. J Virol 2003;77:5401-5414.
26. Tan YJ, Lim SP, Ng P, Goh PY, Lim SG, Tan YH, Hong W: CD81 engineered with endocytotic signals mediates HCV cell entry: Implications for receptor usage by HCV in vivo. Virology 2003;308:250-269.
27. Tan YJ, Lim SP, Ting AE, Goh PY, Tan YH, Lim SG, Hong W: An anti-HIV-1 gp120 antibody expressed as an endocytotic transmembrane protein mediates internalization of HIV-1. Virology 2003;315:80-92.
28. Wilkening S, Bader A: Influence of culture time on the expression of drug-metabolizing enzymes in primary human hepatocytes and hepatoma cell line HepG2. J Biochem Mol Toxicol 2003;17:207-213.
29. Wilkening S, Stahl F, Bader A: Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab Dispos 2003;31:1035-1042.